5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
4:00 pm
The EQuaTR conference, hosted by ITM’s Chicagoland CTSA partner NUCATS, offers professionals in clinical and translational research the opportunity to gain additional knowledge on current trends and issues in clinical research for application in their...
12:00 am
The EQuaTR conference, hosted by ITM’s Chicagoland CTSA partner NUCATS, offers professionals in clinical and translational research the opportunity to gain additional knowledge on current trends and issues in clinical research for application in their...
Prentice Women’s Hospital
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
Mar
29
Wed
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Mar 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Apr
13
Thu
DEADLINE: Enhancing Quality in the Translational Research (EQuaTR) Workforce Conference Registration
Apr 13 @ 4:00 pm
DEADLINE: Enhancing Quality in the Translational Research (EQuaTR) Workforce Conference Registration

The EQuaTR conference, hosted by ITM’s Chicagoland CTSA partner NUCATS, offers professionals in clinical and translational research the opportunity to gain additional knowledge on current trends and issues in clinical research for application in their professional setting. Topics which will be discussed at the conference include  e-consents, human subjects project regulations, using a single IRB for multi-site research, and how mobile devices are changing patient engagement.

Learn more and register here.

Source: NUCATS

May
4
Thu
Enhancing Quality in the Translational Research (EQuaTR) Workforce Conference @ Prentice Women’s Hospital
May 4 all-day
Enhancing Quality in the Translational Research (EQuaTR) Workforce Conference @ Prentice Women’s Hospital | Chicago | Illinois | United States

The EQuaTR conference, hosted by ITM’s Chicagoland CTSA partner NUCATS, offers professionals in clinical and translational research the opportunity to gain additional knowledge on current trends and issues in clinical research for application in their professional setting. Topics which will be discussed at the conference include  e-consents, human subjects project regulations, using a single IRB for multi-site research, and how mobile devices are changing patient engagement.

Learn more and register here.

Source: NUCATS

Jul
31
Mon
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Jul 31 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Nov
29
Wed
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Nov 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Mar
29
Thu
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Mar 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Jul
30
Mon
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Jul 30 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS